Davy Research

Symrise

Q4 EBITDA behind, driven by Scent & Care
Foods
Symrise

DAVY VIEW

Symrise has reported another impressive year for organic growth, led by its Flavours and Nutrition divisions (+8.3%). Q4 EBITDA was 4.3% behind expectations, driven by a slowdown in organic growth and a lower Scent & Care margin. Looking to FY 2018, the group expects to outperform its relevant markets (revenue terms) and deliver an EBITDA margin of “around 20%” (consensus: 21.3%) despite the current inflationary raw material environment. There remains good momentum in the business with Q1 having started well. Market estimates are likely to nudge lower on the back of raw material and FX headwinds.

Download full report with analyst certification and important disclosures
Download
Download full report with analyst certification and important disclosures
Download
  • RATINGS AND PRICE CORRECT AT TIME OF ISSUE


  • Symrise

    Closing Price: 6554c

  • RATING 21/06/12

  • PREVIOUS RATING N/A

Analyst(S)

COMPANY DATA

JUMP TO